News

GESA Celltrion Healthcare IBD Fellowship - Applications Now Open!

20 October 2020

$30, 000 Fellowship Available - The GESA Celltrion Healthcare IBD Fellowship is to assist a trainee who wishes to further their training as a fellow in IBD-related gastroenterology. The intention is to help train a future leader in the field who will promote clinical excellence and advance research in IBD during their subsequent career.

Read More

Risk of euDKA in colonoscopy patients with type 2 diabetes

01 October 2020

Over the last few years there has been an increasing number of reports of patients with type 2 diabetes who are taking SGLT2i developing severe diabetic ketoacidosis (DKA) requiring ICU or HDU admission, particularly during the peri-operative period.

Read More

World Hepatitis Day - Let's Talk Hep C!

07 September 2020

World Hepatitis Day, observed on July 28 every year, aims to raise global awareness of hepatitis — a group of infectious diseases known as Hepatitis A, B, C, D, and E — and encourage prevention, diagnosis and treatment. In 2020 World Hep Day was supported by the Gastroenterological Society of Australia with the presentation of an informative and interactive webinar that provided perspectives from leading physicians and community members and a Q&A session.

Practical management of IBD patients during the COVID-19 pandemic

13 July 2020

The COVID‐19 pandemic, caused by the novel coronavirus SARS‐CoV‐2, has emerged as a public health emergency and challenged healthcare systems globally. This review aims to summarise the current literature and provide guidance on the management of inflammatory bowel disease patients in the context of the COVID‐19 pandemic in the Australasian setting.

Read More

Removal of the bulk billing requirement relating to patients under 16 years and for patients at risk of COVID-19

20 April 2020

The Minister for Health has confirmed today the removal of the bulk billing requirement relating to patients under 16 years and for patients at risk of COVID-19 - these changes are effective today. Normal billing practices will now apply.

Read More

Impacts of the COVID-19 pandemic on GI and liver researchers in Australia

17 April 2020

GESA Research and Grants Committee Chair, Nina Tirnitz-Parker, and GESA President, Simone Strasser, have prepared a statement regarding the severe impact on all research activity of the COVID-19 pandemic.

Read More

Principles for clinicians caring for paediatric gastroenterology patients during the COVID-19 pandemic

07 April 2020

GESA Paediatric Network Chair, Edward Giles, and GESA President, Simone Strasser, have prepared a statement of principles for clinicians caring for paediatric gastroenterology patients during the COVID-19 pandemic.

Read More

GESA Colonoscopy Recertification Program suspended to assist colonoscopists during COVID-19 pandemic

02 April 2020

In light of the disruptive times caused by the COVID-19 pandemic the GESA Board and the Colonoscopy Recertification Committee have resolved to suspend the Colonoscopy Recertification Program until at least 30 September 2020.

Read More

Principles for clinicians caring for patients with IBD during the COVID-19 pandemic

26 March 2020

The GESA IBD Faculty, in collaboration with Crohn’s & Colitis Australia (CCA), has developed this guidance for clinicians caring for patients with inflammatory bowel disease (IBD) during the COVID-19 pandemic.

Read More

Recommendations for patients with inflammatory bowel disease (IBD) during the COVID-19 pandemic

26 March 2020

The GESA IBD Faculty, in collaboration with Crohn’s & Colitis Australia (CCA), has developed these recommendations for people living with inflammatory bowel disease (IBD) during the COVID-19 pandemic.

Read More

Guide for triage of endoscopic procedures during the COVID-19 pandemic

26 March 2020

To support endoscopists and health systems in appropriately restricting endoscopic procedures, GESA provides the following triage guide.

Read More

Updated GESA statement on COVID-19 and endoscopy units

20 March 2020

Arthur Kaffes Chair, GESA Faculty of Endoscopy and Simone Strasser President, have prepared a statement of recommendations for all medical and nursing staff involved in endoscopic practice.

Read More

Impact of COVID-19 on patients with gastrointestinal and liver disorders

19 March 2020

Cases of novel Coronavirus infection (COVID-19) are rapidly increasing in the Australian community as they are in most countries around the world. Information about this new viral infection is rapidly changing and it is important to stay up to date with advice from federal and state-based departments of health.

Read More

Australia's first public stool bank is paying people to donate their poo for faecal transplants

10 March 2020

BiomeBank is funded by the Hospital Research Foundation and processes and stores healthy stool so it can be distributed to hospitals around the country and overseas. The stool is used for patients requiring faecal microbiota transplantation (FMT), a breakthrough treatment with a 90 per cent cure rate of chronic bowel disorders.

Read More

Nonalcoholic fatty liver disease burden: Australia, 2019 – 2030

27 February 2020

Nonalcoholic fatty liver disease (NAFLD) is recognized as a cause of advanced liver disease globally and particularly in Australia where the increasing burden of metabolic syndrome is reflected in national survey data.

Read More